Melissa R. Kaufman

TL;DR: A targeted hospital discharge date of postoperative day 1 can be achieved in the majority of patients who underwent radical prostatectomy and these patients can be treated on the same clinical pathway, according to a prospectively evaluated cohort of patients.

TL;DR: Safety data suggest autologous muscle derived cells for urinary sphincter repair at doses of 10, 50, 100 and 200×10(6) cells appears safe, and efficacy data suggest a potential dose response with a greater percentage of patients responsive to higher doses.

TL;DR: Certain toileting behaviors, of which some may be considered unhealthy, were common in this sample of women and most were associated with a perception of bladder problems, which have important implications for defining bladder health and implementing behavior based interventions for women with lower urinary tract symptoms.

TL;DR: A significant prevalence of voiding dysfunction is identified among women with orthotopic neobladder after radical cystectomy and preoperative discussion of these possible complications is recommended to establish realistic expectations.

TL;DR: The purpose of this study was to find the rate of urinary retention in clinical practice after treatment with onabotulinumtoxinA (BTN/A) for refractory overactive bladder symptoms and determine factors that predict this outcome.